Low-Dose Thalidomide and Dexamethasone Improves Survival in Advanced Multiple Myeloma

Reviewer: Ryan Smith, MD
OncoLink
Ultima Vez Modificado: 10 de diciembre del 2002

Translation for this article does not exist